Skip to content

DR. PIRSOUL

Active
Private limited companyfounded 2016active for 10 yearsWeverstraat 100, 2531 Boechout, BelgiumKBO/BCE: BE 0652.813.463
Summary

DR. PIRSOUL has been active since 2016 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €18,600 and a net result of €331,854. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 9% of 20,649 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Risk analysisFollow ReportCompare
DR. PIRSOULActiveChecked score 91/100
Risk analysis ReportCompare

Overview

Activity
Specialist medical practice
NACE 86220
1 site
Size
≈ €740,000turnover 2025, estimated
Equity
€18,600
Profit
€331,854
Turnover estimated from the gross margin
Financial health
91 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Structure
2025 accounts 81 days early1 of 4 deeds summarised
Why 91raises riskEquity €18,600 (4.2% of total assets)lowers riskSector: Human health activities (NACE 86)Size: total assets €442,780Figures for financial year 2025 (filed 12-05-2026)Show the evidence

Checked score

Score 2025
91 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 25% of its sector peers (NACE 86, micro)
Every signal that counts is listed under Signals.
Financial strength · tick = 2024
Average
Solvency 29-71
equity 4.2% of total assets
Liquidity 28-49
short-term debt 79.0% · cash 16.8%
Profitability 100=
return on assets 74.9%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,153 companies, NACE 86, micro)
Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025lowest value 11-2025: < 0.1%● unchanged vs 10-2025lowest value 12-2025: < 0.1%● unchanged vs 11-2025lowest value 01-2026: < 0.1%● unchanged vs 12-2025lowest value 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026highest value 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026
Credit of up to €1,500 on 30-day terms is acceptable
Liquidity insufficient (current ratio 0.92, compared with 4.77 in 2024, below 1; short-term debt: 79% and cash: 16.8% of total assets), and 95.8% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 10% on solvency, 5% on liquidity, 80% on profitability and 4% on growth.

The bankruptcy probability was computed on 30-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Size: total assets €442,780
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
raises risk · Equity €18,600 (4.2% of total assets)
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed 12-05-2026)
NBB · annual accounts
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 9% of 20649 sector peers (2025).
NBB · sector comparison
Position among 20649 sector peers
Solvency
better than 9%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 11-05-2026, 81 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
81 days early
2024
28 days early
2023
22 days early
2022
60 days early
2021
32 days early
2020
17 days late
2019
22 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 33 days before the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 29 June (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
30-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. Annual accounts filedfinancial year 2024 · micro…
  3. Highest result from 2018 to 2025net €334,879 ▲22.2%

Key points

  • Caution: Equity fell in 2025from €353,747 to €18,600 ▼ 94.7% View
  • Caution: Among the weakest 10% on solvencysector median 63.0% · 20,649 companies 4.2% View
  • Positive: 8 profitable years in a rowprofit 2025: €331,854 8 years View
  • Positive: Filed on time since financial year 2021accounts within the deadline every year 5 years View

By topic

Financials

Financial year
2025
Total assets
€442,780
Profit
€331,854
Solvency
4.2%
Total assets▲ 1.2%
Net result
20182025
Go to Financials

Timeline

Events
15
Since
2017
Next accounts
by 31-07-2027
  1. 09-07-2024Annual accounts filed
  2. 31-12-2023Liquidity more than doubled
  3. 23-11-2023Resignation: PIRSOUL Stéphane (manager)
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Specialist medical practiceNACE 86220
Founded
25-04-2016
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Articles of association

Provisions read
18
Annual meeting
First Tuesday of May at 10:00
Purpose
“Het uitoefenen,organiseren,bevorderen en structureren van alle beroepsactiviteiten op het…” (deed in Dutch)
Go to Articles of association

Key facts about DR. PIRSOUL

What is the company number of DR. PIRSOUL?
0652.813.463. In Belgium the VAT number is the company number with BE in front: BE 0652.813.463.
Where is DR. PIRSOUL based?
The registered office is at Weverstraat 100, 2531 Boechout.Company details
What does DR. PIRSOUL do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of DR. PIRSOUL?
Private limited company (BV).
When was DR. PIRSOUL founded?
On 25-04-2016.
Is DR. PIRSOUL still active?
Yes, DR. PIRSOUL is an active enterprise in the KBO register.
What is the turnover of DR. PIRSOUL?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.Financials
Is DR. PIRSOUL profitable?
In financial year 2025, DR. PIRSOUL made a profit of €331,854.
Where can I find the annual accounts of DR. PIRSOUL?
DR. PIRSOUL filed 10 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DR. PIRSOUL due?
By 31-07-2027, for financial year 2026.Timeline

Companies related to DR. PIRSOUL

Go further with this company

How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure